Tandem Diabetes Care, Inc. Cash and Restricted Cash
Tandem Diabetes Care, Inc. (TNDM) had Cash and Restricted Cash of $62.82 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-06
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $62.82M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $179.32M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $90.63M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $91.95M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents as first filed |
|---|---|---|
| 2026-06-30 | $62.82M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $179.32M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $90.63M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $91.95M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $64.11M 10-Q · filed 2026-08-06 | |
| 2025-03-31 | $53.57M 10-Q · filed 2026-05-07 | |
| 2024-12-31 | $69.23M 10-Q · filed 2026-08-06 | |
| 2024-09-30 | $49.04M 10-Q · filed 2025-11-06 | |
| 2024-06-30 | $47.70M 10-Q · filed 2025-08-06 | |
| 2024-03-31 | $58.98M 10-Q · filed 2025-04-30 | |
| 2023-12-31 | $58.87M 10-K · filed 2026-02-19 | |
| 2023-09-30 | $79.61M 10-Q · filed 2024-11-06 | |
| 2023-06-30 | $130.75M 10-Q · filed 2024-08-01 | |
| 2023-03-31 | $127.76M 10-Q · filed 2024-05-02 | |
| 2022-12-31 | $172.52M 10-K · filed 2026-02-19 | |
| 2022-09-30 | $123.79M 10-Q · filed 2023-11-01 | |
| 2022-06-30 | $114.97M 10-Q · filed 2023-08-03 | |
| 2022-03-31 | $93.68M 10-Q · filed 2023-05-03 | |
| 2021-12-31 | $71.18M 10-K · filed 2025-02-26 | |
| 2021-09-30 | $112.38M 10-Q · filed 2022-11-02 | |
| 2021-06-30 | $98.58M 10-Q · filed 2022-08-03 | |
| 2021-03-31 | $120.79M 10-Q · filed 2022-05-04 | |
| 2020-12-31 | $94.61M 10-K · filed 2024-02-21 | |
| 2020-09-30 | $129.48M 10-Q · filed 2021-11-03 | |
| 2020-06-30 | $222.48M 10-Q · filed 2021-08-04 | |
| 2020-03-31 | $74.48M 10-Q · filed 2021-05-05 | |
| 2019-12-31 | $51.17M 10-K · filed 2023-02-22 | $51.17M 10-K · filed 2020-02-24 |
| 2019-09-30 | $46.06M 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $38.16M 10-Q · filed 2020-07-30 | |
| 2018-12-31 | $41.83M 10-K · filed 2022-02-22 | |
| 2018-06-30 | $60.55M 10-Q · filed 2018-07-30 | |
| 2018-03-31 | $72.58M 10-Q · filed 2018-04-26 | |
| 2017-12-31 | $23.70M 10-K · filed 2021-02-24 | |
| 2017-06-30 | $37.35M 10-Q · filed 2018-07-30 | |
| 2017-03-31 | $48.33M 10-Q · filed 2018-04-26 | |
| 2016-12-31 | $46.68M 10-K · filed 2020-02-24 | $44.68M 10-Q · filed 2018-04-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |